• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment impact on COVID-19 evolution in hemodialysis patients.

作者信息

Chawki Sylvain, Buchard Albert, Sakhi Hamza, Dardim Karim, El Sakhawi Karim, Chawki Mokhtar, Boulanger Henri, Kofman Tomek, Dahmane Djamal, Rieu Philippe, Attaf David, Ahriz-Saksi Salima, Besson Frederic, Boula Remy, Hafi Ali, Massoumi Afshin, Diddaoui Ali Zineddine, Fromentin Luc, Michaut Patrick, Nebbad Rachida, Desassis Jean-François, Nicolet Laurence, Ghazali Abderrahmane, Sohier-Attias Julie, Lamriben Larbi, Adem Arezki, Dupuis Emmanuel, Rifard Mohamad-Khair, Joly Dominique, El Karoui Khalil, Attias Philippe

机构信息

Institut Universitaire d'hématologie, Hôpital Saint-Louis, Institut national de la santé et de la recherche médicale (INSERM), Unité U944, Paris, France.

BIOS Health, Cambridge, UK.

出版信息

Kidney Int. 2020 Oct;98(4):1053-1054. doi: 10.1016/j.kint.2020.07.010. Epub 2020 Aug 1.

DOI:10.1016/j.kint.2020.07.010
PMID:32750459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7395814/
Abstract
摘要

相似文献

1
Treatment impact on COVID-19 evolution in hemodialysis patients.治疗对血液透析患者新冠病毒肺炎病情演变的影响
Kidney Int. 2020 Oct;98(4):1053-1054. doi: 10.1016/j.kint.2020.07.010. Epub 2020 Aug 1.
2
COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?新冠病毒与透析单位：我们目前了解到了什么以及我们应该怎么做？
Am J Kidney Dis. 2020 Jul;76(1):1-3. doi: 10.1053/j.ajkd.2020.03.008. Epub 2020 Mar 23.
3
COVID-19 and dialysis: why we should be worried.新型冠状病毒肺炎与透析：我们为何应感到担忧。
J Nephrol. 2020 Jun;33(3):401-403. doi: 10.1007/s40620-020-00737-w.
4
Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report.一名血液透析患者同时感染新冠病毒和副流感病毒：病例报告
Clin Nephrol. 2020 Oct;94(4):207-211. doi: 10.5414/CN110164.
5
Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities.对透析设施中的新型冠状病毒肺炎感染采取积极措施。
J Formos Med Assoc. 2020 May;119(5):895-897. doi: 10.1016/j.jfma.2020.03.022. Epub 2020 Apr 11.
6
In-ICU COVID-19 patients' characteristics for an estimation in post-ICU rehabilitation care requirement.用于评估重症监护病房后康复护理需求的新冠肺炎重症监护病房患者特征。
Anaesth Crit Care Pain Med. 2020 Aug;39(4):479-480. doi: 10.1016/j.accpm.2020.06.002. Epub 2020 Jun 13.
7
Lung ultrasound: a valuable tool for the assessment of dialysis patients with COVID-19.肺部超声：评估新冠肺炎透析患者的一项重要工具。
Clin Exp Nephrol. 2020 Sep;24(9):850-852. doi: 10.1007/s10157-020-01903-x. Epub 2020 May 19.
8
Role of Screening for COVID-19 in Hemodialysis Wards, Results of a Single Center Study.血液透析病房中新冠病毒病筛查的作用：一项单中心研究结果
Iran J Kidney Dis. 2020 Sep;14(5):389-398.
9
COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island.终末期肾病患者中的新型冠状病毒肺炎感染：纽约市和长岛透析机构前瞻性疾病监测项目的结果
J Am Soc Nephrol. 2020 Nov;31(11):2517-2521. doi: 10.1681/ASN.2020070932. Epub 2020 Oct 19.
10
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Apr 29;16(N° 691-2):876.

引用本文的文献

1
COVID-19 vaccine in hemodialysis patients: Time for a boost.COVID-19 疫苗在血液透析患者中的应用：是时候加强了。
Saudi Med J. 2023 Sep;44(9):882-888. doi: 10.15537/smj.2023.44.9.20230285.
2
The Characteristics, Dynamics, and the Risk of Death in COVID-19 Positive Dialysis Patients in London, UK.英国伦敦 COVID-19 阳性透析患者的特征、动态和死亡风险。
Kidney360. 2020 Sep 10;1(11):1226-1243. doi: 10.34067/KID.0004502020. eCollection 2020 Nov 25.
3
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
4
Long-term impact of COVID-19 among maintenance haemodialysis patients.新冠病毒病对维持性血液透析患者的长期影响
Clin Kidney J. 2021 Sep 27;15(2):262-268. doi: 10.1093/ckj/sfab166. eCollection 2022 Feb.
5
SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers.感染六个月后血液透析患者与医护人员体内的新型冠状病毒2抗体比较
Int J Nephrol. 2021 Dec 1;2021:4747221. doi: 10.1155/2021/4747221. eCollection 2021.
6
Presentation and outcomes of chronic kidney disease patients with COVID-19.慢性肾脏病合并 COVID-19 患者的临床表现和结局。
J Bras Nefrol. 2022 Jul-Sep;44(3):321-328. doi: 10.1590/2175-8239-JBN-2021-0071.
7
Transmission of SARS-CoV-2 considering shared chairs in outpatient dialysis: a real-world case-control study.考虑到在门诊透析中共享椅子，SARS-CoV-2 的传播：一项真实世界的病例对照研究。
BMC Nephrol. 2021 Sep 16;22(1):313. doi: 10.1186/s12882-021-02518-4.
8
Continuing arteriovenous fistula creation by nephrologist and its outcome during COVID pandemic-Analysis of 376 cases.在 COVID 大流行期间，由肾病学家继续进行动静脉瘘管的创建及其结果分析-376 例病例分析。
Semin Dial. 2022 Jan;35(1):3-5. doi: 10.1111/sdi.13010. Epub 2021 Sep 8.
9
Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2.对先前感染过严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的透析患者进行单剂量BNT162b2 mRNA疫苗接种后的体液免疫反应
Front Med (Lausanne). 2021 Aug 17;8:721286. doi: 10.3389/fmed.2021.721286. eCollection 2021.
10
The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review.《COVID-19 大流行时代血液透析患者的脆弱世界：系统范围界定综述》。
J Nephrol. 2021 Oct;34(5):1387-1403. doi: 10.1007/s40620-021-01136-5. Epub 2021 Aug 21.

本文引用的文献

1
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1.
2
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
3
Covid-19 and Kidney Transplantation.新冠病毒-19与肾移植
N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session.血液透析患者心血管疾病伴血浆 ACE 和 ACE2 失衡及其单次透析过程中的变化。
Ren Fail. 2017 Nov;39(1):719-728. doi: 10.1080/0886022X.2017.1398665.
6
Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients.血液透析患者肾素-血管紧张素系统的某些方面
Kidney Blood Press Res. 2015;40(6):614-22. doi: 10.1159/000368537. Epub 2015 Nov 29.
7
Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease.慢性肾脏病患者的血管紧张素转换酶 2 活性。
Nephrol Dial Transplant. 2013 Sep;28(9):2287-94. doi: 10.1093/ndt/gft038. Epub 2013 Mar 27.